Potential cerebrospinal fluid metabolomic biomarkers and early prediction model for Parkinson’s disease
Year: 2025
Type: article
Abstract: Objective: To identify key cerebrospinal fluid (CSF) metabolomic biomarkers associated with Parkinson's disease (PD) and prodromal PD, providing insights for intervention strategy development. Methods: Six hundred and thirty-nine participants from the Parkinson's Progression Markers Initiative (PPMI) cohort were included: 300 PD patients, 112 healthy controls (HC), and 227 prodromal PD patients. Regression analysis and OPLS-DA identified metabolic biomarkers, while pathway analysis examined their relationship to clinical features. An XGBoost-based early prediction model was developed to assess the distinction between PD, prodromal PD, and HC. A two-sample bidirectional Mendelian randomization analysis was performed to examine the association between differential metabolites and Parkinson's disease. Results: Sixty-four metabolites were significantly altered in PD patients compared to HC, with 58 elevated and 6 reduced. In prodromal PD, 19 metabolites were increased, and 34 were decreased. Key metabolic pathways involved glutathione and amino acid metabolism. Dopamine 3-O-sulfate correlated with PD progression, levodopa-equivalent dose, and non-motor symptoms. The XGBoost model demonstrated high specificity in predicting the onset of PD. The MR analysis results showed a positive correlation between higher genetic predictions of dopamine 3-O-sulfate levels and the risk of Parkinson's disease. In contrast, the reverse MR analysis found that Parkinson's disease susceptibility significantly increased dopamine 3-O-sulfate levels. Conclusion: The differential expression of CSF metabolites reveals early cellular metabolic changes, providing insights for early diagnosis and monitoring PD progression. A bidirectional causal relationship exists between genetically determined PD susceptibility and metabolites.
Source: Frontiers in Aging Neuroscience
Institution: Shenzhen Bao'an District People's Hospital
Language: English
Subfield: Neurology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W4410905333